-
Spain high-speed train collision kills 31, injures 80
-
UK comedian Brand tells rape trial 'consent is fundamental'
-
Turkey hosted Libya east-west reunification talks last week
-
Shadman guides Bangladesh to 213-3 in West Indies Test
-
Spain high-speed train collision kills 30
-
Tech optimism lifts stocks ahead of Fed update on rates
-
Plane reportedly carrying Brazil's Bolsonaro departs Ecuador
-
No penalty practice for Fleetwood hero Haughey before he downs Arsenal
-
Springboks pick six uncapped players for Nations Championship
-
Billionaire Ambani's Jio soars in market debut after India's biggest IPO
-
Israel's unassuming President Herzog holds keys to next government
-
Cross-border abductions threaten Kenya's status as dissident refuge
-
Real Madrid apologise to China over Mbappe comments
-
'Eat the rich': Indonesians protest against graft, wildfires
-
Three killed by storm in southern India
-
Netanyahu bloc leads as Israeli votes counted, but no majority
-
China says takes Mbappe apology 'seriously' after Mao remark
-
Cyclone eases after lashing India coast, no deaths reported
-
Flavio Bolsonaro on way to Ecuador from Argentina after fleeing Brazil
-
AI chip giant SK hynix posts seven-fold surge in quarterly operating profit
-
Netanyahu bloc leads after half of Israeli votes counted but no majority
-
Two hundred 'Cruise for life' passengers stranded in Cambodia
-
India vows action after first cheetah shot dead
-
Pierce Brosnan and Helen Mirren on the joys of filming 'MobLand'
-
'Now or Never': Ethiopia influencers push for Eritrea invasion
-
S.African activists push back on data centre rush
-
Mbappe furore rages on in China, but Mao comments censored
-
Judges set to rule on Australian mushroom killer's appeal
-
Billionaire Ambani's Jio jumps 21% in market debut after record India IPO
-
Syria reopens Jordan border crossing after mending ties
-
Rays win thriller to thwart Brewers in World Series
-
Cyclone Arnab lashes India coast, no deaths reported
-
Reigning champ Knicks earn first win against Pistons
-
Trump tamed after US midterms? Europe doubts it
-
Runners swap streets for shopping malls as haze chokes Singapore
-
Tech stocks soar as SK hynix adds to rising AI confidence
-
Billionaire Ambani's Jio to debut after record India IPO
-
Sri Lanka's Tamil farmers fight to reclaim land after civil war
-
UK set for cautious budget as borrowing costs climb
-
Afghans compete for jobs, homes as millions return
-
Anthropic's record IPO faces some big questions
-
'They don't care about us': Trump food aid cuts leave Americans struggling and angry
-
US Fed expected to hold rates steady ahead of key midterm elections
-
Meta, Snap head to trial in another case about social media's harms
-
Can this Latin Grammy-winner help Democrats win back Congress?
-
French Senate passes bill to make protesters pay for unrest damage
-
Tuvalu has 'limited' power to halt its fossil fuel investments: NZ govt papers seen by AFP
-
India evacuates tens of thousands as Cyclone Arnab makes landfall
-
Palestinian activist Khalil returns to Columbia after US detention
-
In tight Israel vote, both camps hold out cautious hope
Norwegian effectively cured of HIV after transplant from brother
A Norwegian man has been effectively cured of HIV after receiving a stem cell transplant from his brother, doctors announced on Monday.
The patient's brother happened to carry a rare, virus-blocking genetic mutation.
The 63-year-old man, dubbed the "Oslo patient", is the latest in around 10 people worldwide who have gone into long-term remission from HIV after receiving a transplant to treat unrelated blood cancer.
The high-risk procedure normally requires a donor to have a specific mutation of their CCR5 gene, which blocks HIV from entering the body's cells.
Only around one percent of people in northern Europe have the necessary mutation.
The Oslo patient, who had been living with HIV since 2006, was diagnosed with a fatal blood cancer called myelodysplastic syndrome in 2017.
His doctors searched for a donor who would help treat both. When they couldn't find one, they chose the man's elder brother.
However, on the day of the transplant in 2020, the doctors were stunned to discover that the brother carried the CCR5 mutation.
"We had no idea... That was amazing," doctor Anders Eivind Myhre of the Oslo University Hospital told AFP.
- 'Winning the lottery twice' -
The patient said "it was like winning the lottery twice", added Myhre, who was also the lead author of a study describing the case in Nature Microbiology.
Two years after the transplant, the patient stopped taking the anti-retroviral drugs which had been reducing the level of HIV in his body.
The researchers found no trace of the virus in samples of the man's blood, gut and bone marrow.
"For all practical purposes, we are quite certain that he is cured," Myhre said.
Now the Oslo patient, whose name was not revealed, is "having a great time" and has more energy than he knows what to do with, Myhre said.
The painful and potentially dangerous transplant procedure is for people who have both HIV and deadly blood cancer so is not a feasible option for the millions of people living with the virus across the world.
However, researchers believe that studying these rare cases will reveal more about how HIV works in the hope of finding a cure for all patients.
- 'No longer a patient' -
The Oslo patient is the first person to receive a transplant from a family member.
The patient's immune system had been "completely replaced" by the donor's, sqaid study co-author Marius Troseid of the University of Oslo.
It was the first time this had been observed in a cured patient's bone marrow and gut, he told AFP.
Even before the researchers found out the brother had a CCR5 mutation, they had some hope that the Oslo patient's HIV could be cured.
That is because in 2024 it was revealed that the so-called "next Berlin patient" entered long-term remission despite receiving a transplant that did not have two copies of the mutated gene.
The original Berlin patient, Timothy Ray Brown, was the first person declared cured of HIV back in 2008. Patients in London, New York, Geneva, Duesseldorf and elsewhere followed.
Given the Oslo patient's robust health, Troseid suggested that his nickname was no longer suitable.
"The Oslo patient is perhaps no longer a patient. At least he doesn't feel like it," Troseid said.
E.Gasser--VB